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Disrupted circadian rhythms is a prominent and early feature of neurodegenerative diseases
including Huntington’s disease (HD). In HD patients and animal models, striatal and hypo-
thalamic neurons expressing molecular circadian clocks are targets of mutant Huntingtin
(mHtt) pathogenicity. Yet how mHtt disrupts circadian rhythms remains unclear. In a genetic
screen for modifiers of mHtt effects on circadian behavior in Drosophila, we discovered a
role for the neurodegenerative disease gene Ataxin2 (Atx2). Genetic manipulations of Atx2
modify the impact of mHtt on circadian behavior as well as mHtt aggregation and demon-
strate a role for Atx2 in promoting mHtt aggregation as well as mHtt-mediated neuronal dys-
function. RNAi knockdown of the Fragile X mental retardation gene, dfmr1, an Atx2 partner,
also partially suppresses mHtt effects and Atx2 effects depend on dfmr1. Atx2 knockdown
reduces the cAMP response binding protein A (CrebA) transcript at dawn. CrebA transcript
level shows a prominent diurnal regulation in clock neurons. Loss of CrebA also partially
suppresses mHtt effects on behavior and cell loss and restoration of CrebA can suppress
Atx2 effects. Our results indicate a prominent role of Atx2 in mediating mHtt pathology, spe-
cifically via its regulation of CrebA, defining a novel molecular pathway in HD pathogenesis.
Author summary
Circadian clocks evolved to anticipate 24 h environmental rhythms driven by the earth’s
daily rotation and regulate nearly all aspects of behavior, physiology and the genome. Dis-
ruptions of the circadian clock have been associated with a wide range of human diseases,
including neurodegenerative diseases such as Huntington’s disease (HD). Using an HD
animal model in which a mutant Huntingtin (mHtt) protein is expressed, we identify a
role for the RNA binding protein and neurodegenerative disease gene Ataxin-2 (Atx2) in
mediating mHtt effects on circadian behavioral rhythms. Using transcriptomics, we iden-
tify the transcription factor CrebA as a potential target of both Atx2 and the circadian







Citation: Xu F, Kula-Eversole E, Iwanaszko M, Lim
C, Allada R (2019) Ataxin2 functions via CrebA to
mediate Huntingtin toxicity in circadian clock
neurons. PLoS Genet 15(10): e1008356. https://
doi.org/10.1371/journal.pgen.1008356
Editor: Gaiti Hasan, National Centre for Biological
Sciences, TIFR, INDIA
Received: February 12, 2019
Accepted: August 7, 2019
Published: October 8, 2019
Copyright: © 2019 Xu et al. This is an open access
article distributed under the terms of the Creative
Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in
any medium, provided the original author and
source are credited.
Data Availability Statement: All RNA-seq files are
available from the GEO database (GSE136378 and
GSE136381).
Funding: The research was supported by DARPA
(D12AP00023). The content of the information
does not necessarily reflect the position or the
policy of the Government, and no official
endorsement should be inferred. F.X. was
supported by the Training Grant in Circadian and
Sleep Research (T32HL007909). The funders had
no role in study design, data collection and
clock. Finally, we demonstrate a role for CrebA in mediating mHtt effects on circadian
behavior, defining a novel Atx2-CrebA pathway in a neurodegenerative disease model.
These studies define the molecular mechanisms by which mHtt can disrupt circadian
rhythms identifying potential novel therapeutic targets for this uniformly fatal disease.
Introduction
Circadian disruption is prevalent in Huntington’s disease (HD) patients and animal models.
HD is caused by a triplet (CAG) expansion in the Huntingtin gene (Htt) resulting in expansion
of a polyglutamine (polyQ) repeat (mHtt), mHtt aggregation, degeneration of striatal medium
spiny neurons, and characteristic involuntary motor symptoms [1, 2]. In addition, circadian
behavioral rhythms are strongly disrupted in HD patients [3–5] and in animal models [5–8].
In fact, circadian and/or sleep changes often appear even before the characteristic motor symp-
toms [9–13].
Impaired rhythmicity is typically accompanied by physiological, cellular, and molecular
changes in circadian pacemaker neurons. Clock-driven rhythms in melatonin are altered In
HD patients [14, 15]. In postmortem HD brains, the numbers of master circadian pacemaker
neurons in the hypothalamic suprachiasmatic nucleus (SCN) are reduced, especially of the
subset expressing the neuropeptide vasoactive intestinal peptide (VIP) [16]. Similarly, in flies,
mHtt expression selectively reduces the number of a subset of clock neurons, the small ventral
lateral neurons (sLNv), important for free running circadian behavior [7]. The core molecular
clock is also impacted in mouse models with disruptedmPer2 ormBmal1mRNA oscillations
in both the SCN [5, 6]. The core circadian oscillator is evident outside of the SCN, including in
the striatum, and striatal molecular oscillations are also altered suggesting that there are com-
mon mHtt mechanisms between the SCN and striatum.
To address the mechanisms by which mHtt impacts circadian behavior, we are employing
the fruit fly Drosophila. As in mammals, the circadian behavior is driven by a focused set of
pacemaker neurons. Of special importance are those expressing the neuropeptide Pigment
Dispersing Factor (PDF), subdivided into ~4 sLNv and ~4 large LNv per hemisphere [17, 18].
PDF-expressing sLNvs are especially important for maintaining robust rhythmicity under con-
stant darkness conditions [19–21]. Nevertheless, even a single sLNv is sufficient to maintain
behavioral rhythmicity [18].
Within these clock neurons, a molecular negative feedback loop, largely conserved between
invertebrates and vertebrates, is responsible for behavioral rhythms. In flies, the CLOCK
(CLK)/CYCLE(CYC) heterodimer directly activates the transcription of period (per) and time-
less (tim) with peak mRNA expression occurring in the early night [22–24]. In turn, PER and
TIM work in concert to repress CLK/CYC activation [24, 25]. Phosphorylation and ubiquiti-
nation result in PER/TIM degradation and initiation of a new transcriptional cycle every 24
hours [26–30]. CLK/CYC also directly activate transcription of vrille (vri) and Pdp1ε [31], also
peaking in the early night. VRI and PDP1 feedback to control rhythmic Clk expression [31,
32]. Translational control of per especially in the LNv is also critical for molecular and behav-
ioral rhythms. Of note, this pathway involves the neurodegenerative disease gene Ataxin2
(Atx2) and its partner tyf which interact with the polyA binding protein (PABP) to promote
PER translation [33–35]. Of note Atx2 can also repress translation via an alternative TYF-inde-
pendent pathway to control rhythms in the LNv [36]. This alternative pathway involves
miRNA-mediated silencing [37] and may function with the Drosophila homolog of the Fragile
Mental Retardation gene Fmr1 [38, 39].
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Expressing human Htt with varying polyQ lengths in Drosophila recapitulates features of
HD. These effects include polyQ length dependence [40], locomotor impairment [40–43],
cytoplasmic or nuclear aggregate formation [43, 44], and neurodegeneration [43]. Molecular
mechanisms discovered in fly HDmodels are conserved with those found in mammalian
models, including mTor-induced autophagy [45], histone acetylation [46–48], SUMOylation/
ubiquitination [49], and axonal transport [50, 51]. mHtt also strongly disrupts sleep and/or cir-
cadian behavioral rhythms [6–8, 52–55] as well as selective loss of PDF in sLNv circadian clock
neuron cell bodies [7, 55]. Despite the conservation of disrupted circadian rhythms in HD and
HDmodels, the molecular mechanisms by which mHtt impacts circadian behavior remain
unclear.
Results
Atx2 as a potent dose-dependent mediator of mHtt effects
To discover genes important for mHtt effects on circadian rhythms, we performed an RNAi
screen to look for modifier effects of mHtt induced arrhythmicity by expressing HttQ128 in
PDF+ LNv using PdfGAL4 (PdfGAL4/UAS-HttQ128) [43, 55, 56] (S1 Fig). By day 10, we
observe a substantial reduction in PDF+ sLNv cell body numbers consistent with published
data (S1 Table) [55, 57]. As our previous data suggest that the circadian clock modifies mHtt
effects [56], we focused on clock-controlled genes in PDF+ LNv. Here we focus on the stron-
gest modifier of HttQ128 from this screen, Ataxin2 (Atx2; S1 Fig). Atx2 is an RNA-binding
protein and a translational regulator most well known for its role in spinocerebellar ataxia type
2 [37, 58, 59]. Atx2 displays a modest rhythm in the LNvs, consistent with clock control (S2
Fig; gammaBH = 0.045). Validating a role for Atx2, we found that two independent Atx2
RNAi lines (Atx2 RNAi TRiP#2 (TRiP.HMS02726), and #1(TRiP.HMS01392)) partially sup-
press HttQ128 effects on behavioral rhythms (Fig 1A, S2 Table, S3 Fig). These effects persist in
older flies (Fig 1A). Given that Atx2 had also been previously shown to play a role in circadian
behavior, we also examined Atx2 RNAi effects in in HttQ0 controls but did not find any signif-
icant effect on rhythms (Fig 1A, S3 Fig, S2 Table). To determine if these effects were unique to
our HttQ128 model, we also tested a mHtt containing exon 1 with a polyQ of 103 (HttQ103)
[40]. We found that expression of HttQ103 in PDF clock neurons strongly reduced behavioral
rhythmicity [56] (Fig 1B, S4 Fig, S2 Table). Importantly, RNAi mediated knockdown of Atx2
also partially suppressed this arrhythmicity (Fig 1B, S4 Fig, S2 Table). We also assessed mHtt
induced loss of cell body expression of the PDF neuropeptide in Atx2 RNAi flies. While wild-
type flies typically have 4 PDF+ sLNv cell bodies/hemisphere [60], HttQ128 expressing flies
only exhibit about<1 /hemisphere by day 10 post-eclosion, a time when circadian behavior is
significantly affected (S1 Table). We found that Atx2 RNAi did not significantly affect sLNv
PDF cell body number on its own nor HttQ128 mediated PDF cell body loss (p = 0.06), sug-
gesting that the improved rhythmicity may be principally due to an alteration in mHtt-induced
neuronal dysfunction (Fig 1C). To determine if Atx2 effects mHtt induced aggregation, we
employed a GFP tagged mHtt transgene, HttQ72 [40]. We were unable to identify an antibody
which would enable visualization of HttQ128 aggregation and HttQ103 exhibits aggregates too
quickly to observe changes in the process. By day 7 post-eclosion, we observe aggregates (see
Methods) in about ~30% of sLNv neurons. We did not observe any significant effects on PDF
cell body number or on circadian behavior in these flies around this age (S4 and S5 Tables).
Strikingly, these aggregates are undetectable in HttQ72-GFP flies co-expressing Atx2 RNAi
(Fig 1D and 1E).
Atx2 RNAi knockdown with a different line (VDRC100423, KK108843) has been associated
with a reduction in behavioral rhythmicity in the absence of mHtt [33, 35]. We wanted to
Atx2, CrebA and mHtt toxicity
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Fig 1. Atx2 partially suppresses mHtt induced circadian arrhythmicity and aggregation. A. Rhythmic power (P-S) is indicated for various genotypes
including flies expressing HttQ0 (Pdf>HttQ0 in grey) or HttQ128 (Pdf>HttQ128 in blue) in PDF neurons in a TRiP RNAi library control background
(TRiP Ctrl attP2 and attP40) and expressing two independent Atx2 TRiP RNAi lines (Atx2 TRiP #1 and #2; n = 12–41; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005,
error bars represent standard error). Rhythmic power (P-S) is indicated for aged flies expressing HttQ128 in PDF neurons in a TRiP RNAi library
control background (TRiP Ctrl attP40) or expressing Atx2 TRiP RNAi (Atx2 TRiP #2, in orange). Flies were at the age of day 9–17 during DD behavior.
B. Rhythmic power (P-S) is indicated for various genotypes including flies expressing HttQ25 or HttQ103 in PDF neurons (Pdf>HttQ25 or
Pdf>HttQ103 in green) in PDF neurons in a TRiP RNAi library control background (TRiP Ctrl attP2 and attP40) and expressing two independent
Atx2 TRiP RNAi lines (Atx2 TRiP #1 and #2; n = 18–42; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard error). C. The number of sLNv
PDF cell bodies per brain hemisphere at age day 10 is indicated for various genotypes where either Atx2 RNAi (Atx2 TRiP#2) or TRiP RNAi library
control (TRiP Ctrl attP40) together without (n = 4–6) or with HttQ128 are expressed is shown (n = 19–26; ⇤p<0.05 ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars
Atx2, CrebA and mHtt toxicity
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determine if this line (KK) also modified mHtt. First, we confirmed that Atx2 knockdown
with this line suppressed rhythms as previously reported (S5A Fig). Also as expected given the
poor rhythms on their own, we failed to see an improvement of rhythms in mHtt expressing
flies (S5A Fig). Nonetheless, we tested this line for its effect on mHtt-induced sLNv PDF cell
body loss and aggregation. In contrast to the other Atx2 lines tested (Fig 1A), we observed a
modest increase in PDF+ sLNv cell body number (S5B Fig, p = 0.0026). We also tested the
effects of this line on mHtt induced aggregation, in this case, using HttQ46-GFP which exhib-
its significant aggregation in the sLNv by age day 30. Nonetheless, these Q46 flies did not show
a reduction in PDF+ sLNv cell body number and they still exhibited robust rhythms at this age
(S4 and S5 Tables). Here we confirmed that Atx2 knockdown reduced aggregation, further
confirming a role for Atx2 in this process. (S5C Fig). Taken together, these results collectively
confirm a role of Atx2 knockdown in mediating mHtt aggregation.
To address whether Atx2 effects on mHtt are dose-dependent, we tested the effect of Atx2
overexpression (PdfGAL4/UAS-Atx2; Atx2OX). Given that we expect Atx2 overexpression
would enhance mHtt effects, we used the HttQ103 model which retains more residual rhyth-
micity than Pdf>HttQ128. Here we found that Atx2OX significantly reduced rhythmicity in
HttQ103 flies (Fig 2A, S6 Fig, S3 Table). However, it also had a significant behavior reduction
in a HttQ25 flies suggesting that the effects are not polyQ dependent(Fig 2A, S6 Fig, S3 Table).
Effects in a wild-type background also trended to reduced rhythms although they did not
reach statistical significance(Fig 2A, S6 Fig, S3 Table). To assess its effects on mHtt aggrega-
tion, we co-expressed Atx2 with HttQ46-GFP in PDF neurons. We found that nuclear GFP
signal was more aggregated and enhanced in Atx2 OX flies in the lLNvs compared to the wild-
type controls (Fig 2B and 2C, yellow arrows). In the sLNv, no aggregates are evident in wild-
type flies but are now observable in the Atx2OX flies (Fig 2B and 2C, orange arrows). Thus,
down or up-regulating Atx2 can suppress or enhance, respectively, mHtt aggregation effects.
The PABP-binding domain but not the LSM domain, nor tyf is critical for
Atx2 effects on mHtt
Atx2 functions via direct association with target RNAs and the polyA binding protein (PABP)
[61, 62]. These functions are accomplished via two conserved domains: the PAM2 domain,
important for interactions with PABP and the Like Smith (Lsm) domain, which binds RNA
[61, 63]. The Lsm domain is also important for interactions with the PER translational regula-
tor TYF [33]. To elucidate the functions of these domains, we overexpressed Atx2 lacking the
PAM2 domain (UAS-Atx2-dPAM) or the Lsm domain (UAS-Atx2-dLsm). Consistent with
our prior report [33], expression of two of the three independent transgenic insertions of
Atx2-dPAM significantly reduced rhythmicity when expressed without mHtt (S7 and S8A
Figs). Yet despite this reduced rhythmicity, all three lines significantly improve rhythmicity in
HttQ128 expressing flies with limited effects in HttQ0 expressing flies (Fig 3A, S2 Table). On
the other hand, Atx2-dLsm modestly reduced rhythms in a HttQ0 and HttQ128 expressing
background (Fig 3A, S2 Table). Since HttQ128 rhythmicity is already very poor, we also over-
expressed Atx2-dLsm in the more rhythmic Pdf>HttQ103 background and PDF>HttQ25
controls but partial suppression of rhythms was observed in both strains similar to wild-type
represent standard error). D. Percentage of sLNvs (labeled with PDF in red) at age day 7 containing HttQ72-eGFP aggregates (in green) in a TRiP RNAi
library control background (TRiP Ctrl attP40) and expressing a Atx2 TRiP RNAi lines (Atx2 RNAi TRiP #2) is quantified (n = 27–41; ⇤p<0.05,
⇤⇤p<0.01, ⇤⇤⇤:p<0.005). E. Representative images of sLNv and lLNv for corresponding genotypes in D are shown. White arrowheads indicate lLNvs.
White dot circles label sLNvs in the merged figure. Orange dash circles label sLNvs with aggregates while blue dot circles label sLNvs without aggregates
in the grey scale of the green channel. Example aggregates are pointed out by orange arrows.
https://doi.org/10.1371/journal.pgen.1008356.g001
Atx2, CrebA and mHtt toxicity
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Atx2 overexpression (S3 Table). Strong rhythm reductions of UAS-Atx2-dPAM in the HttQ25
background precluded a simple assessment in the HttQ103 strain, although reductions by
Atx2-dPAM were not observed in Q103 (S3 Table) To determine the basis of improved
rhythms in Atx2-dPAM flies, we assessed PDF+ sLNv cell body number and found significant
increases in all three Atx2-dPAM lines (Fig 3B). Notably, the differences between the lines in
terms of effects on mHtt induced arrhythmicity and aggregation (#6,8>#7) parallel their
effects on PER and overall transgenic expression levels (S8B–S8D Fig). We also hypothesize
that the Atx2 TRiP lines may be weaker than the KK line previously published to reduce
rhythms in the absence of mHtt. To test this possibility, we quantified effects on PER levels in
the LNv after Atx2 RNAi knockdown (S8C Fig). Consistent with previous observations [33],
we observed reduced PER levels with the KK line. However, we also observed a similar
Fig 2. ATX2 overexpression enhances mhtt aggregation. A. Rhythmic power (P-S) is indicated for various genotypes including flies expressing ATX2
in PDF neurons (UAS-Atx2) or in the wild-type control background (W1118) together with HttQ25 or HttQ103 (Pdf>HttQ25 or Pdf>HttQ103
n = 22–64; ⇤:p<0.05 ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard error) B. Percentage of sLNvs (labeled with PDF in red) at age day 7
containing HttQ72-eGFP aggregates (in greee) in a wild-type background (W1118) and overexpressing ATX2 (UAS-Atx2) is quantified (n = 15–25;
⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005). C. Representative images of sLNv and lLNv for corresponding genotypes in B are shown. White arrowheads indicate
lLNvs. White dot circles label sLNvs in the merged figure. Orange dash circles label sLNvs with aggregates while blue dot circles label sLNvs without
aggregates in the grey scale of the green channel. Example aggregates are pointed out by orange arrows.
https://doi.org/10.1371/journal.pgen.1008356.g002
Atx2, CrebA and mHtt toxicity
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reduction of PER with the TRiP #2 line, suggesting that the differences between the two lines
may not be via their effects on PER. These Atx2-dPAM lines also reduced HttQ46-GFP aggre-
gates in the LNvs (Fig 3C). Taken together, the data suggest that the PAM2 domain but not the
Lsm domain in Atx2 mediates its enhancement of mHtt toxicity.
Atx2 interacts with TYF to regulate the translation of PER in the LNv [34]. To determine if
tyfmediates Atx2 effects on mHtt, we examined mHtt induced PDF cell body loss and aggre-
gates in a loss-of-function tyfemutant. Because of the critical role of tyf in PER translation and
Fig 3. ATX2 lacking the PABP-binding (PAM2) domain reduces mHtt toxicity while Atx2 lacking the Lsm domain does not. A. Rhythmic power
(P-S) is indicated for various genotypes including flies expressing three independent overexpression line of ATX2 lacking PAM2 domain and one
overexpression line of ATX2 lacking Lsm domain in PDF neurons (Atx2-dPAM#7/6/8 and Atx2-dLsm#9) together with HttQ0 (Pdf>HttQ0; n = 12–
39) or HttQ128 (Pdf>HttQ128; n = 7–44; ⇤:p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard error) is shown. B. The number of sLNv
present per brain hemisphere at day 10 is indicated for various genotypes where either ATX2 lacking PAM2 domain (Atx2-dPAM#6/7/8) or wild-type
control (Ctrl) together with HttQ128 are expressed in PDF neurons is shown (n = 15–19; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent
standard error). C. Representative images of sLNv and lLNv expressing HttQ46-eGFP at age day 30 are shown in the wild-type control background
(Ctrl) or with ATX2-dPAM overexpression (Atx2-dPAM#6/7/8). White arrowheads indicate lLNvs without aggregates while orange arrow head
indicates lLNvs with aggregates. Asterisks label sLNvs. Example aggregates are pointed out by orange arrows.
https://doi.org/10.1371/journal.pgen.1008356.g003
Atx2, CrebA and mHtt toxicity
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the profound arrhythmicity of tyfmutants [34], we did not assess their behavioral rhythms.
However, we failed to observe any significant effect of tyf loss on sLNv cell body number either
with HttQ128 (S9A Fig) or without it (S9B Fig). Nor did it affect the % of sLNv containing
HttQ72 aggregates (S9C and S9D Fig). These results are consistent with our previous observa-
tion that PDF+ sLNv cell body number is not affected in per0mutants expressing HttQ128
[56]. Thus, these data suggest that Atx2 effects are independent of its role in PER translation.
Atx2 affects PolyQ but not mutant TDP43 mediated toxicity
Given that Atx2 has been implicated in other neurodegenerative diseases, we asked if the Atx2
effects seen here are specific to mHtt or not. To test this, we examined two other neurodegen-
erative models that can reduce behavioral rhythms when expressed in PDF neurons. First, we
found expression of another polyQ protein, ATXN3Q78, involved in Machado-Joseph disease
[64, 65] and a mutant form of Tar Domain Protein 43 (TDP43-A315T), which is involved in a
familial autosomal dominant form of amyotrophic lateral sclerosis [66, 67] in PDF neurons
results in a robust reduction in overall rhythmicity. The finding of reduced rhythms with
ATXN3Q78 by expression in clock cells was previously observed [68]. Similar to what has
been shown for mHtt, Atx2 knockdown or Atx2-ΔPAM overexpression partially suppresses
the arrhythmicity of ATXN3Q78 expression (Fig 4A, S10 Fig). On the other hand, no suppres-
sion was observed in the case of TDP43-A315T-induced arrhythmicity, indicating that Atx2
Fig 4. Atx2 reduction or ATX2 lacking the PAM domain rhythmic power improves behavioral rhythms in MJDQ78 but not
mutant TDP43 models. A. Rhythmic power (P-S) is indicated for various genotypes including flies expressing only PdfGAL4 in the
wild-type control background (Pdf X Ctrl(WT)) as well as flies expressing ATX3Q78 (MJDQ78) in PDF neurons in a TRiP RNAi
library control background (MJDQ78 TRiP Ctrl#2) and expressing Atx2 RNAi lines (MJDQ78 Atx2 TRiP #2) or in wild-type control
background (Ctrl) and overexpression of Atx2 lacking PAM domain (MJDQ78 Atx2-dPAM#8; n = 5–17; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:
p<0.005, error bars represent standard error). B. Rhythmic power (P-S) is indicated for various genotypes including flies expressing
only PdfGAL4 in the RFP expressing background (Pdf X Ctrl(RFP)) as well as flies expressing mutant TDP43 (TDP43A315T) in
PDF neurons in a TRiP RNAi library control background (TDP43A315T TRiP Ctrl#2) and expressing Atx2 RNAi lines
(TDP43A315T Atx2 TRiP #2) or in wild-type control (Ctrl) background and overexpression of Atx2 lacking PAM domain
(TDP43A315T Atx2-dPAM#8; n = 9–15; NS:not significant, ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard error).
https://doi.org/10.1371/journal.pgen.1008356.g004
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effects are specific to polyQ toxicity (Fig 4B, S10 Fig). We have previously observed suppres-
sion of these TDP43 effects using sgg [56] a known TDP43 suppressor [69].
Atx2 effects do not necessarily function via reductions in mHtt expression
Atx2 effects may modify mHtt effects on behavior (Q128 or Q103) and aggregation (Q72 or
Q46) by reducing mHtt levels either by reducing the activity of the PdfGAL4 driver or by a
more direct effect on mHtt, for example, by reducing mHtt translation. The former is inconsis-
tent with our finding that PdfGAL4 driven UAS-TDP43A315T effects on circadian behavior
are unaffected by Atx2 knockdown (Fig 4B). To address this question, we assessed changes in
GFP fluorescence in the sLNv expressing HttQ25-GFP and HttQ46-GFP driven by PdfGAL4
using Atx2 manipulations. As aggregation can stabilize HttQ46-GFP, we addressed levels in
younger flies (day 2) prior to the appearance of aggregates. As Atx2 overexpression can trigger
premature aggregation (Fig 5A and 5B), we also focused our analysis on those sLNvs which
did not show aggregation. While we observed significant reductions in HttQ25 and HttQ46-
GFP expression with Atx2 RNAi, levels of HttQ25 nor HttQ46 were not affected either by
Atx2-dPAM nor Atx2 overexpression. As we quantified aggregation with Q72-eGFP (Fig 2B)
but assessed non-aggregated levels in Q46 and Q25, we cannot exclude the possibility that
Atx2 functions to regulate the levels of HttQ72 in a polyQ length-dependent manner to more
indirectly regulate Q72 aggregation. In either case, Atx2 effects may operate via both changes
in Htt levels but likely by other mechanisms that impact aggregation.
TheDrosophila homolog of the fragile X mental retardation gene Fmr1 and
Atx2 partner is important for mHtt effects on circadian rhythms and clock
neurons
ATX2 also interacts with FMR1 and they may work together via a miRNA pathway to control
protein translation [38, 39]. Specific RNAs bound by FMR1 are downregulated in Fmr1 knock-
out mice, implying FMR1 could not only silence gene expression but also stabilize its targets
[70] FMR1 is most well known for its role in Fragile X syndrome also due to a triplet repeat
expansion in the 5’ untranslated region of the FMR1 gene [71]. Notably, those carrying premu-
tations, i.e., those with intermediate length expansions, also exhibit a neurodegenerative syn-
drome resulting in ataxia potentially due to an alternative translation of the triplet repeat
sequence [72]. To test whether loss of Fmr1 can also modify Htt effects used RNAi knock-
down. We found that Fmr1 knockdown with two independent RNAi lines (Fmr1 RNAi
TRiP#1, (TRiP.HMS00248) and, Fmr1 RNAi TRiP#2, (TRiP.GL00075)) can improve rhyth-
micity in HttQ128 expressing flies (Fig 6A, S11 Fig, S2 Table), while they have little or no effect
when expressed in a HttQ0 background (Fig 6A).). We confirmed these rhythm enhancing
effects in the HttQ103 background (Fig 6B, S11 Fig, S3 Table). We also confirmed Fmr1
knockdown in both strains, one (TRiP #2) using elavGAL4 and the other (TRiP #1; adult lethal
with elavGAL4) and with pdfGAL4 (S12 Fig). We assayed PDF+ sLNv cell body number and
aggregation and observed a modest increase in PDF+ sLNv cell body number with one line
reaching statistical significance (Fig 6C, p = 0.0063), although there is not a statistical differ-
ence between the two RNAi lines. Moreover, both lines reduce the percentage of sLNvs that
contains HttQ72 aggregates (Fig 6D and 6E). These data suggest that Atx2 and Fmr1 work
together to regulate mHtt toxicity.
To test the hypothesis that Atx2 and Fmr1 work together, we co-expressed Atx2 and Fmr1
RNAi constructs and assayed the effects on HttQ128-induced rhythm suppression. If the
genes operate independently then we would expect that Atx2 and Fmr1 effects on rhythmic
power would be additive, i.e., knockdown of both genes would be more rhythmic than either
Atx2, CrebA and mHtt toxicity
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gene alone. On the other hand we found that neither Atx2 nor Fmr1 knockdown could
improve rhythmicity if expression of the other gene were knocked down (Fig 7, S13 Fig, S2
Table). For one combination, rhythmic power may even be reduced when both are knocked
down relative to single RNAi controls. The interdependence of Atx2 and Fmr1 effects are con-
sistent with published data that the two proteins interact and function together [73].
Fig 5. Atx2 knockdown decreases Htt and mHtt levels while Atx2 or Atx2-dPAM overexpression does not affect
Htt or mHtt levels prior to aggregation formation. A. GFP Intensity in the sLNv for flies expressing HttQ25 (Q25) or
HttQ46 (Q46) in a TRiP RNAi library control background (TRiP Ctrl#2) and expressing Atx2 RNAi lines (Atx2 TRiP
#2) at age day 5 is quantified and shown. GFP Intensity in the sLNv without aggregates formed for flies expressing
HttQ25 (Q25) or HttQ46 (Q46) in a wild-type control background (Ctrl) and expressing UAS-Atx2 and UAS-dPAM
at age day 2 is quantified and shown (n = 5–38; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005). B. Representative images of LNvs
(sLNv and lLNv) expressing HttQ46-eGFP at age day 2 are shown in wild-type control background (Ctrl) and
overexpressing Atx2 or Atx2 lacking the PAM domain (UAS-dPAM). Blue arrowheads indicate lLNvs. Blue circles
label sLNvs without aggregates. Orange dash circles label sLNvs with nuclear accumulation/aggregation of HttQ46
(which were not used for GFP intensity quantification).
https://doi.org/10.1371/journal.pgen.1008356.g005
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Fig 6. Fmr1 knockdown partially suppresses mHtt toxicity. A. Rhythmic power (P-S) is indicated for various genotypes including
flies expressing HttQ0 (Pdf>HttQ0 in grey) or HttQ128 (Pdf>HttQ128 in blue) in PDF neurons in a TRiP RNAi library control
background (TRiP Ctrl attP2) and expressing two independent Fmr1 TRiP RNAi lines (Fmr1TRiP #1 and #2; n = 13–41; ⇤p<0.05,
⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard error). B. Rhythmic power (P-S) is indicated for various genotypes including
flies expressing HttQ25 or HttQ103 in PDF neurons (Pdf>HttQ25 or Pdf>HttQ103 in green) in PDF neurons in a TRiP RNAi
library control background (TRiP Ctrl attP2) and expressing two independent Fmr1 TRiP RNAi lines (Fmr1TRiP #1 and #2; n = 16–
42; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard error). C. The number of sLNv present per brain hemisphere is
indicated for various genotypes where either two independent Fmr1 RNAi (Fmr1 TRiP #1/2) or TRiP RNAi library control (TRiP
Ctrl) and HttQ128 are expressed is shown (n = 9–14; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005). D. Percentage of sLNvs (labeled with PDF in
red) at age day 7 containing HttQ72-eGFP aggregates (in green) in a TRiP RNAi library control background (TRiP Ctrl) and
Atx2, CrebA and mHtt toxicity
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Atx2, but not tyf, regulates the diurnal cycling of CrebA
To discover potential gene-specific targets of Atx2 action, we conducted RNA sequencing
from flow activated cell sorted PDF+ LNvs in which we co-expressed Atx2 RNAi (KK108843).
While Atx2 effects are thought to be primarily posttranscriptional, we reasoned that changes
in RNAmetabolism, including translation, could affect RNA half-life and, as a result, RNA
levels [74, 75]. We assessed the effects of Atx2 RNAi at dawn and dusk ZT0/2 and ZT12/14
(around light-on and lights-off in 12:12 LD cycles). In order to find Atx2 regulated genes,
we employed DEseq2 with an adjusted p-value threshold< 0.05. Atx2 is robustly knocked
down by>75% validating RNAi efficiency (Fig 8A). 960 differentially expressed genes were
found at ZT0-2 with 1243 differentially expressed genes at ZT12-14. Among these, 396
genes were differentially expressed at both time points. As this Atx2 RNAi line is known to
disrupt PER expression and circadian rhythms [34, 35], we expected to observe changes in
core clock genes. We observed significant increases in vri at ZT0 and reductions in tim at
expressing two independent Fmr1 TRiP RNAi lines (Fmr1 TRiP #1/2) is quantified (n = 32–65; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005,
error bars represent standard error). E. Representative images of sLNv and lLNv for corresponding genotypes in D are shown. White
arrowheads indicate lLNvs. White dot circles label sLNvs in the merged figure. Orange dash circles label sLNvs with aggregates while
blue dot circles label sLNvs without aggregates in the grey scale of the green channel. Example aggregates are pointed out by orange
arrows.
https://doi.org/10.1371/journal.pgen.1008356.g006
Fig 7. Atx2 and Fmr1 effects on HttQ128 toxicity depend on each other. Rhythmic power (P-S) is indicated for various genotypes
including flies expressing HttQ0 (Pdf>HttQ0 in grey) or HttQ128 (Pdf>HttQ128 in blue) in PDF neurons in a TRiP RNAi library
control background (TRiP Ctrl attP2) and expressing two independent Fmr1 TRiP RNAi lines (Fmr1TRiP #1 and #2) or expressing
both Atx2 and Fmr1 RNAi together (Atx2 TRiP#2;Fmr1 TRiP #1 and Atx2 TRiP#2;Fmr1 TRiP#2; n = 10–41; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:
p<0.005, error bars represent standard error; n = 10–32). Some control data is reproduced from Fig 6.
https://doi.org/10.1371/journal.pgen.1008356.g007
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ZT12 (Fig 8B and 8C). As ATX2’s binding partner in PER translation initiation, TYF also
strongly affects the core clock [34]. Genes that are misregulated in both Atx2 RNAi and tyf
mutant could be more likely due to their effect on the clock, such as vri and tim (Fig 8E and
8F). Since Atx2 affects and tyfmutant does not affect mHtt toxicity, we reasoned that Atx2
Fig 8. Reduction in Atx2 but not tyf reduces peak LNv CrebA expression. A-D. The expression level of various genes of interest (Atx2, vri, tim,
CrebA) in flies expressing mGFP in the LNvs in a wild-type background (WT) or with the expression of Atx2 RNAi KK (Atx2 KD) at two time points is
shown in normalized counts calculated by DEseq2. E-G. The expression level of various genes of interest (vri, tim, CrebA) in flies expressing mGFP in
the LNvs in the wild-type background (WT) or in the tyfmutant (tyf(e)) at two time points is shown in normalized counts calculated by DEseq2.
Asterisks indicate the significance using the adjusted p-values calculated by DEseq2 (⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard
error).
https://doi.org/10.1371/journal.pgen.1008356.g008
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function in mHtt toxicity would be via genes that are selectively regulated by Atx2 and not tyf.
We similarly FACS sorted LNv from wild-type and tyfmutants and found 429 genes were
found differentially regulated at both time points (ZT4 and ZT16), 98 of which were also regu-
lated by Atx2 RNAi. Among the remaining 298 Atx2-dependent, tyf-independent genes, one
was cyclic AMP response element-binding protein A (CrebA; Fig 8D). CrebA also showed a
significant difference (~3x) between ZT0/2 and ZT12/14 consistent with an underlying oscil-
lation, one which was previously observed with a similar phase at the protein level in the LNv
[76]. We find that Atx2 RNAi significantly reduces CrebA levels at ZT0 and mildly elevated
CrebA at ZT12 while there was not a significant effect in tyfmutants (Fig 8G). Thus, our data
suggest that Atx2 dependent regulation of diurnally cycling CrebAmay be critical for mHtt
toxicity.
CrebA knockdown suppresses mHtt effects on behavior, PDF cell body loss,
and aggregation and CrebA overexpression can suppress Atx2 RNAi
behavioral effects
To determine if CrebA affects mHtt, we assayed its effect on mHtt-mediated arrhythmicity.
CrebA overexpression affects circadian period length [76]. Nonetheless, we identified one
RNAi line (CrebA RNAi TRiP#2 (TRiP.JF02189)) that does not reduce rhythmicity on its own
(Fig 9A, S14 Fig, S2 Table). However, this line partially rescues the arrhythmicity caused by
HttQ128 (Fig 9A, S14 Fig, S2 Table). To confirm that the phenotype was due to CrebA, we
used a transgenic rescue of Creb RNAi. We found that CrebA expression did indeed suppress
Creb RNAi improvement of HttQ128-induced arrhythmicity, while it did not reduce
HttQ128 rhythms without CrebA RNAi (Fig 9B, S14 Fig, S3 Table). Knocking down CrebA
also improves arrhythmicity caused by HttQ103, while not affecting HttQ25 (Fig 9C), con-
firming CrebA as a modifier for mHtt induced arrhythmicity.
To understand how CrebA regulates mHtt toxicity, we assayed effects on PDF+ sLNv cell
body number and mHtt aggregation. CrebA knockdown increased sLNv cell body number
from<1 to ~2 (Fig 10A, p = 0.00064). CrebA RNAi also nearly eliminated HttQ72-GFP aggre-
gates in the sLNv (Fig 10B and 10C). To determine if the reduction of mHtt toxicity and aggre-
gation was via a reduction in GAL4–driven Htt levels, we assessed the effects of CrebA RNAi
on non-aggregation prone HttQ25-GFP driven by PdfGAL4. In fact, we find that CrebA RNAi
modestly increases HttQ25-GFP levels (Fig 10D). Although we cannot exclude a polyQ-depen-
dent effect, our data suggest that changes in mHtt aggregation are not likely due to a reduction
in mHtt levels. Our model predicts that downregulation of CrebA at dawn may mediate Atx2
effects on mHtt. If so, then we would predict that restoration of CrebA levels after Atx2 RNAi
knockdown would suppress the rhythm enhancing effects of Atx2 reduction. In fact we find
that CrebA overexpression can, in fact, the rhythm enhancing effects of Atx2 knockdown
while it has little effect on HttQ128 behavioral rhythms on its own (Fig 11, S15 Fig, S2 Table).
Taken together, these data provide powerful evidence for a role of CrebA as a mediator of Atx2
effects on mHtt toxicity.
Discussion
Using a behavioral platform for identifying modifiers of mHtt toxicity, we have identified a
novel molecular pathway in which Atx2 activates CrebA expression to promote mHtt aggrega-
tion and toxicity. Atx2 effects are bidirectional, where loss-of-function using RNAi knock-
down or a ΔPAM dominant negative mutant reduce mHtt effects while overexpression
increases mHtt effects. Loss of Fmr1, a partner of Atx2, showed similar phenotypes suggesting
ATX2 functions with FMR1 in miRNA-mediated translational control. Indeed, the effects of
Atx2, CrebA and mHtt toxicity
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Atx2 and Fmr1 each depend on the expression of the other gene. Transcriptome analysis of
Atx2 regulated gene expression demonstrated a role in increasing CrebA transcript levels at
dawn. Indeed, CrebA knockdown also reduces mHtt toxicity and overexpression can suppress
Atx2 RNAi effects, demonstrating a novel molecular pathway by which Atx2 controls mHtt
toxicity.
Using multiple independent reagents, we demonstrate a potent role for Atx2 in mediating
mHtt toxicity on clock neurons. To reduce Atx2 function, we applied both RNAi-mediated
knockdown and a dominant negative form of Atx2 that is missing the PABP binding PAM2
Fig 9. CrebA knockdown suppresses mHtt induced arrhythmicity in two different mHtt models. A. Rhythmic
power (P-S) is indicated for various genotypes including flies expressing HttQ0 (Pdf>HttQ0 in grey) or HttQ128
(Pdf>HttQ128 in blue) in PDF neurons in a TRiP RNAi library control background (TRiP Ctrl attP2) and expressing
a CrebA TRiP RNAi line (CrebA TRiP #2; n = 14–34; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard
error). Rhythmic power B. Rhythmic power (P-S) is indicated for various genotypes including flies expressing HttQ128
in PDF neurons in a TRiP RNAi library control background (TRiP Ctrl attP2) and expressing a CrebA TRiP RNAi line
(CrebA TRiP#2) or a CREBA overexpression line (UAS-CrebA) or the combination of RNAi and overexpression
(UAS-CrebA;CrebA TRiP#2; n = 20–34; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard error). C.
Rhythmic power (P-S) is indicated for various genotypes including flies expressing HttQ25 or HttQ103 in PDF
neurons (Pdf>HttQ25 or Pdf>HttQ103 in green) in PDF neurons in a TRiP RNAi library control background (TRiP
Ctrl attP2) and expressing a CrebA TRiP RNAi lines (CrebA TRiP#2; n = 19–42; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error
bars represent standard error). Rhythmic power.
https://doi.org/10.1371/journal.pgen.1008356.g009
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Fig 10. CrebA knockdown suppresses mHtt induced PDF+ cell body loss and aggregation despite elevated Htt
levels.A. The number of sLNv present per brain hemisphere at age day 10 is indicated for various genotypes where
either CrebA RNAi (CrebA TRiP#2) or TRiP RNAi library control (TRiP Ctrl) without (n = 4–6) and with HttQ128 are
expressed is shown (n = 20–26; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard error). B. Percentage of
sLNvs (labelled in red) at age day 7 containing HttQ72-eGFP aggregates (in green) in a TRiP RNAi library control
background (TRiP Ctrl) and expressing a CrebA TRiP RNAi lines (CrebA TRiP#2) is quantified (n = 43–44; ⇤p<0.05,
⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard error). C. Representative images of sLNv and lLNv for
corresponding genotypes in B are shown. White arrowheads indicate lLNvs. White dot circles label sLNvs in the
merged figure. Orange dash circles label sLNvs with aggregates while blue dot circles label sLNvs without aggregates in
the grey scale of the green channel. Example aggregates are pointed out by orange arrows. D. GFP Intensity in the
sLNv or lLNv for flies expressing HttQ25 in a TRiP RNAi library control background (TRiP Ctrl) and expressing
CrebA RNAi is quantified and shown (n = 8–20; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard error).
https://doi.org/10.1371/journal.pgen.1008356.g010
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domain crucial for its translation activation function [34]. We observed partial suppression of
mHtt-induced arrhythmicity with two independent RNAi lines and three independent Atx2Δ-
PAM transgenics. Among the lines that we screened, Atx2 RNAi was the most potent modifier
of mHtt induced arrhythmicity arguing for a crucial role. The effect on aggregation is consis-
tent with those identified for Atx2 RNAi as part of a large scale RNAi screen in an in vitro tis-
sue culture cell model, although these results were not validated in vivo [40]. Bidirectional
effects are evident on mHtt aggregation where Atx2 loss- and gain-of function reduce and
increase aggregation, respectively. The potency and dose sensitivity of Atx2 effects on mHtt
toxicity suggest a key role for this RNA-binding protein.
It should be noted that we describe modifier effects using a variety of mHtt models and in
some cases at different ages. The selection of the model was necessitated by that which was
needed or most appropriate to address a specific hypothesis. While it is possible that each of
the models are distinct and that results are not translatable from one model to another, our
results appear largely consistent across models. Many of our mHtt results are observed during
similar ages during early adult life, i.e., Q128 behavior (d6-12), Q128 PDF cell body loss (d10),
Q103 behavior (d10-16) and Q72 aggregation (d7). While the appearance of aggregates was
not uniformly associated with reduced rhythms, those modifers which reduced aggregation
with Q72 (or Q46) also tended to improve rhythms in Q103 and Q128. The most parimonious
explanation is that the modifier effects in one model are related to the those in the other
model. The ability to examine a single model across metrics will be needed to more directly
Fig 11. CREBA overexpression partially blocks the rescue of mHtt toxicity by Atx2 knockdown. Rhythmic
power (P-S) is indicated for various genotypes including flies expressing HttQ0 (Pdf>HttQ0 in blue) or HttQ128
(Pdf>HttQ128 in red) in PDF neurons in control background (TRiP Ctrl attP2 or W1118) and expressing a Atx2 TRiP
RNAi line (Atx2 TRiP#1) or a CREBA overexpression line (UAS-CrebA) or the combination of both (UAS-CrebA;
Atx2 TRiP#1; n = 15–40; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard error).
https://doi.org/10.1371/journal.pgen.1008356.g011
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test this hypothesis. Nonetheless, the finding that modifers affect toxicity across models and in
some cases, across different ages (e.g., Q46 aggregation at d30) suggest general roles in mediat-
ing mHtt effects.
In addition to behavioral and molecular effects, we also demonstrated that Atx2 can par-
tially suppress mHtt effects on pre-degenerative neuronal dysfunction. We find partial sup-
pression of mHtt-induced arrhythmicity is often accompanied by increases in the number of
PDF+ sLNv cell bodies (Figs 3, 6 and 10) responsible for free-running rhythmicity, indicating
that loss of Atx2 function can reduce mHtt induced PDF cell body loss. However, we also find
that Atx2 RNAi can partially suppress mHtt effects on rhythmicity without changing PDF+
sLNv cell body number. Thus, these effects are likely via partial suppression of mHtt-induced
dysfunction of the remaining neurons. For example, mHtt might impact the neuronal activity
of the remaining neurons resulting in behavioral phenotypes and Atx2 RNAi might reduce
these effects. Differences between the lines (e.g., RNAi and PAM) may reflect differences in
the mechanism of Atx2 inhibition which in turn may result in different pathways being
impacted downstream. Nonetheless, this finding highlights a role for Atx2 in mHtt-induced
neural dysfunction but also the potential of our behavioral screening platform to identify func-
tional pre-degenerative changes. Given that sleep-wake changes often occur even prior to the
advent of full HD symptoms [9, 12, 77], it is possible that these changes could also reflect
potentially reversible neuronal dysfunction. We propose identifying molecular pathways, such
as Atx2, important for mHtt effects prior to cell death may be especially useful to slow or even
prevent the onset of HD.
Our results indicate that Atx2 effects are not via their established role in translation of the
core clock component PER but likely function through a translational repression pathway
involving FMR1. First, we find that Atx2manipulations that have no effect on behavioral
rhythmicity can still partially suppress mHtt induced arrhythmicity and aggregation (Fig 1A).
Loss of the partner of Atx2, tyf, involved in PER translation robustly suppresses rhythmicity
and PER levels but has no effect on mHtt aggregation nor PDF+ sLNv cell body number [34,
35] (S9 Fig). Similarly, deletion of the Lsm domain necessary and sufficient for interactions
with TYF also did not display phenotypes distinct from full length Atx2. On the other hand,
loss of the PAM2 domain important for interactions with PABP mitigated mHtt effects consis-
tent with a role in translational control. Loss of per also fails to alter mHtt induced reduction
in PDF+ sLNv cell body number [56]. In addition to its role in PER translation, Atx2 also plays
a role in miRNA-mediated translational repression [39]. Here we tested the function of an
established parter of ATX2 in this pathway, FMR1. We found that Fmr1 knockdown partially
suppresses mHtt-induced arrhythmicity, aggregation and PDF+ sLNv cell body loss (Fig 6). In
addition, the effects of Atx2 and Fmr1 on mHtt depend on the expression of the other gene.
These data suggest that Atx2 and Fmr1 act in concert to enhance mHtt toxicity. Our data
suggest that Atx2may work via multiple modes, one of which is possibly through regulating
mHtt levels. Using RNAi we observed reductions in the expression of both HttQ25-GFP and
HttQ46-GFP in the sLNv(Fig 5A), suggesting a potential role in regulating Htt translation. On
the other hand, we did not observe changes using either Atx2 overexpression of expression of
the dominant negative Atx2ΔPAM, indicating that Atx2 can exert effects independent of regu-
lating mHtt levels.
To discover potential targets of Atx2, we assessed the transcriptome in the LNv using RNAi
knockdown and discovered that Atx2 effects may be mediated by activating dawn expression
of the transcription factor CrebA. After Atx2 RNAi knockdown, we find that CrebA transcript
levels are substantially reduced at their peak time. Yet these same changes are not observed in
a tyfmutant which similarly impairs the core clock, suggesting a tyf and core clock indepen-
dent mechanism which parallels the divergent effects of Atx2 and tyf on mHtt toxicity.
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Interestingly, the mammalian homologs of CrebA, Creb3L1 or Creb3L2 are up-regulated in
HD iPS cells or mouse models, respectively [78, 79], suggesting that CREBs could be facilitat-
ing the HD pathology. Consistent with this model, we find that CrebA knockdown can par-
tially suppress effects of mHtt on circadian behavior, PDF+ sLNv cell body loss, and
aggregation. The behavioral effects are rescued by a wild-type transgene, providing indepen-
dent evidence for an in vivo function. In fact, CrebA overexpression can suppress the mHtt
modifying effects of Atx2 RNAi. While we cannot rule out a function of the other Atx2-depen-
dent, tyf-independent genes identified in our transcriptomic analysis, these data demonstrate
clearly a role for one of those targets, CrebA, in mediating mHtt effects in vivo.
How might Atx2 regulate CrebA? An AUUUUmotif is enriched in 3’UTRs of genes bound
and stabilized by ATXN2 [61]. Notably, we find multiple AUUUU elements are located in the
fly CrebA 3’UTR. Although whether Fmr1 has a similar effect on CrebA transcript level need to
be further determined, we hypothesize that ATX2 stabilizes CrebA transcripts in the PDF neu-
rons at least in the morning.
In addition to a role for Atx2/CrebA in mHtt induced arrhythmicity, both Atx2 and CrebA
transcripts themselves display time-of-day variation in levels. While Atx2 oscillations are
modest, those for CrebA are much more robust (~3-fold), consistent with other studies that
examine CrebA at the protein level [76]. Moreover, Atx2 appears to be important for CrebA
oscillations. Thus Atx2 and especially CrebAmay represent conduits through which the circa-
dian clock can impact mHtt pathogenesis.
These data on Atx2 effects on mHtt add to other data linking Atx2 to multiple neurodegen-
erative diseases, suggesting that Atx2may be a “master regulator” of neurodegeneration. The
gene name Ataxin2 stems from its role in spinocerebellar ataxia 2 (SCA2) [59] caused by an
inherited polyQ expansion within the gene itself. This results in loss of cerebellar Purkinje neu-
rons and ataxia [80]. Notably disrupted REM sleep has been observed even in those who are
presymptomatic, potentially due to pons degeneration [81–83]. Atx2 is also pivotal for polyQ
mediated neurodegeneration involving other spinocerebellar ataxia genes, Atxn1 and Atxn3.
Atx2 overexpression enhances the toxicity of ATXN3Q78 and ATXN1Q82 while the reduced
Atx2 function can partially suppress ATXN1Q82 toxicity as assayed by fly retinal degeneration
[84, 85]. Atx2 also plays a key role in mediating the toxicity of other proteins involved in ALS,
including TDP43, Fused in Sarcoma (FUS), and C9ORF72 [86–90]. Individuals with interme-
diate length polyQ expansions (Q27-32) of ATXN2 exhibited an elevated risk of developing
ALS [86]. Atx2 can bidirectionally modify the toxicity of the ALS gene TDP43 [86]. Overex-
pression of human Atx2 with intermediate length polyQ expansion enhances C9ORf72
induced neuronal toxicity in mammalian neuronal culture [91] and enhances TDP43 induced
retinal degeneration [92]. Atxn2 KO alleviates TDP43 toxicity in survival rate and locomotor
tests in mice model while Atxn2 KD reduces the recruitment of TDP43 to stress granules in
the human cells [87]. Atx2 also regulates retinal degeneration due to FUS as well as the poly-
glycine-arginine repeats derived from the ALS genes C9ORF72 [93]. Given the multiple roles
of ATX2 in a range of neurodegenerative diseases, we hypothesize that it may be a key thera-
peutic node for their prevention and treatment [94].
Materials and methods
Whole Mount immunostaining
Fly crosses were set under 12:12 LD cycles at 25C. Flies eclosing within 24 hours were
collected and kept under their respective conditions until the ages indicated in each experi-
ment. Adult brains were dissected in PBS (137mM NaCl, 2.7mM KCl, 10mMNa2HPO4 and
1.8mM KH2PO4) within 10 minutes. Then brains were fixed in 3.7% formalin solution for
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30 minutes. Brains were washed with 0.3% PBSTx for 4 times before primary antibody incu-
bation. Primary antibodies were diluted in 0.3% PBSTx with 5% normal goat serum and incu-
bation was done at 4C overnight. Brains were washed for 4 times with 0.3% PBSTx after
primary antibody incubation. Secondary antibodies were diluted in 0.3% PBSTx with 5% nor-
mal goat serum and incubation was done at 4C overnight. Primary antibody dilutions were
done as the followings: mouse anti-PDF (1:800, DSHB), rabbit anti-PDF (1:1000, from Nita-
bach Lab), mouse anti-GFP (1:1000). Secondary antibody dilutions were done as the follow-
ings: anti-mouse Alexa594 (1:800, invitrogen), anti-mouse Alexa488 (1:800, invitrogen), anti-
rabbit Alexa594 (1:800, invitrogen), anti-rabbit Alexa488 (1:800, invitrogen), anti-rabbit
Alexa647 (1:800, invitrogen).
Confocal imaging and data quantification
Fly brains after immunostaining were imaged by Nikon C2 confocal. Data processing and
quantification were done with Nikon NIS Elements. For GFP intensity measurements, the
intermediate stack of each cell was chosen for measuring the mean intensity. Three areas for
each hemisphere were randomly chosen and measured as background. The average of those
three areas were calculated for background mean intensity. Cells in the same hemisphere were
quantified against the same background mean intensity. The final mean intensity for GFP sig-
nal from nlsGFP or HttQ25-eGFP or HttQ46-eGFP for each cell was calculated by mean inten-
sity measured from the middle stack of a cell minus the background mean intensity and then
divided by the background mean intensity. For aggregate quantification, a threshold for inten-
sity was applied to the channel used for imaging Htt aggregates (threshold was usually between
2500 to 3500, and the same threshold was used for control and experimental groups in a cer-
tain experiment). The number of aggregates over the threshold in each cell was counted and
the percentage of cells that contained aggregates was calculated. Z-statistic, and the corre-
sponding p-value, was determined for statistically comparing percentages.
Locomotor activity recording and circadian data analysis
Behavior data recording, processing, plotting and analysis were done mainly as previously
described (Pfeiffenberger et al., 2010a, b). Fly locomotor activity was recorded from the Dro-
sophila Activity Monitoring (DAM) data collection system and then extracted with DAM File
Scan. Rhythmicity was measured by power—significance (P-S), parameters calculated by
ClockLab. Activity actograms were plotted with either Counting Macro or ClockLab. Morning
and evening Index were calculated with normalized activity given by output from Counting
Macro. All flies for behavior were entrained from the embryonic stage (after egg-laying) under
12:12 LD cycles.
Fly stocks
RNAi lines used for screening and other overexpression lines were acquired from Blooming-
ton Stock Center unless indicated separately. UAS-HttQ0/128 were kindly provided by Dr. Lit-
tleton. UAS-HttQ25/46/72/103-eGFP were kindly provided by Dr. Perrimon. UAS-TDP43-
A315T was kindly provided by Dr. Wu. Coding sequence for generating ATX2ΔLsm lines
were amplified with primers: ATX2dN-5N GATCGCGGCCGCATGGGTAACAAGCCCCG
TGGC and ATX-PBC3Xb GATCTCTAGACTGTGGCTGATGCTGCTG. The sequence was
subcloned into a modified pUAS-C5 vector with a C-terminal 3xFLAG tag to generate
UAS-ATX2ΔLsm transgenic lines (see details in [33]).
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RNA sequencing and data analysis
LNvs were labeled with Pdf>mGFP. Fly brains were dissected at certain time points and pro-
cessed as previously described (Kula-Eversole et al., 2010; Nagoshi et al., 2010). RNA from
FACS sorted LNvs were extracted with PicoPure Knits. We synthesized 1st and 2nd strand
cDNA from RNA first with Superscript III and DNA polymerase. Then we amplified the RNA
by synthesizing more RNA from the cDNA template with T7 RNA polymerase. After the sec-
ond round of cDNA synthesis from amplified RNA, the cDNA was submitted to HGAC at the
University of Chicago for library preparation and sequencing. Sequencing was done in HGAC
at University of Chicago with Illumina HiSeq 2000. All samples are done with single-end reads
of 50 base pairs. Reads were quantified against Flybase transcript assembly, release 6.14, using
kallisto (Bray et al., 2016b). Gene-level quantification was obtained using tximport library,
both for TPMs and counts data. Our LNv data comprise of three food/temperature combina-
tion conditions, with 12 time points per each condition: 1.5X Sucrose-Yeast (SY) fly food and
25˚C),0.5X SY fly food and 25˚C and 1.5X SY fly food and 18˚C. Genes which do not pass the
threshold of TPM>1 in at least 50% of samples were filtered out, leaving 7863 genes; condi-
tions were concatenated to generate a dataset contains 36 time points as an input data for Boot
eJTK to determine cycling genes (Hutchison et al., 2018). We applied the Benjamini-Hochberg
(BH) correction method to Gamma p-values calculated by Boot eJTK. BH corrected p-value
of less than 0.05 and fold change greater than 1.5 (between peak and trough) were used as a
threshold for detection of cycling genes. Estimated counts acquired from kallisto were used as
input for DEseq2 for differential expression analysis. Two replicates of ZT0 Atx2 RNAi LNv
samples were compared to wild-type control LNv samples at ZT0 and ZT2 while two replicates
of ZT12 Atx2 RNAi LNv samples were compared to wild-type control LNv samples at ZT12
and ZT14. Similarly, Two replicates of ZT4 tyf mutant LNv samples were compared to wild-
type control LNv samples at ZT2 and ZT4 while two replicates of ZT16 tyf mutant samples
were compared to wild-type control LNv samples at ZT14 and ZT16. All flies from those
experiments were raised under regular food, under 25˚C, 12:12 LD cycles and aged on 1.5X SY
fly food, under 25˚C, 12:12 LD cycles prior to dissections. The significance of differential
expression of genes is determined by the adjusted p-value from DEseq2 (adjp<0.05).
Supporting information
S1 Fig. RNAi screening for mHtt toxicity suppressors identifies an Atx2 RNAi line as the
strongest suppressor. X-axis indicates ranking of screened RNAi lines based on their average
rhythmic power (Power-Significance; P-S) values in Pdf>HttQ128 flies. The red line indicates
the cut-off for RNAi to be considered modifiers, and the red circle (Ctrl) indicates the average
P-S of the control. Two independent Atx2 RNAi lines that are modifiers are indicated by
black. Screen data previously shown [56].
(TIFF)
S2 Fig. Atx2 transcript is identified as cycling in LNvs. Averaged transcript levels in tran-
scripts per million (TPM) for Atx2 across three 24 hour light:dark cycles. Light and dark peri-
ods are indicated in yellow and gray, respectively. Data for each time point is averaged from
three conditions: standard 1.5x sucrose-yeast (SY) food at 25˚C, 0.5xSY at 25˚C,1.5xSY at
18˚C.
(TIFF)
S3 Fig. Actograms for Atx2 RNAi with HttQ0 and HttQ128. A. Double plotted actograms
for individual HttQ0 flies from Fig 1A are shown under 5LD and 7DD cycles. Day number
and Zeitgeber time is indicated on each actogram. B. Double plotted actograms for individual
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HttQ128 flies from Fig 1A are shown under 5LD and 7DD cycles. Day number and Zeitgeber
time is indicated on each actogram.
(TIFF)
S4 Fig. Actograms for Atx2 RNAi with HttQ25 and HttQ103. A. Double plotted actograms
for individual HttQ25 flies from Fig 1B are shown under 5LD and 7DD cycles. Day number
and Zeitgeber time is indicated on each actogram. B. Double plotted actograms for individual
HttQ103 flies from Fig 1B are shown under 5LD and 7DD cycles. Day number and Zeitgeber
time is indicated on each actogram.
(TIFF)
S5 Fig. Independent Atx2 RNAi line rescues PDF positive sLNv loss and aggregation. A.
Rhythmicity (P-S) is indicated for various genotypes including flies expressing an Atx2 KK
RNAi line (Atx2 RNAi KK) or in the KK RNAi library control background only (KK Ctrl)
with either non-toxic control HttQ0 (Pdf>HttQ0, in grey) or toxic HttQ128 (Pdf>HttQ128,
in blue) is shown (n = 8–39; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard
error). B. The number of sLNv present per brain hemisphere at day 10 is indicated for various
genotypes where either Atx2 RNAi (KK) or KK RNAi library control (KK Ctrl) and HttQ128
expression is shown (n = 13–24; ⇤p<0.05 ⇤⇤p<0.01, ⇤⇤⇤:p<0.005). C. Representative images of
LNvs (sLNv and lLNv) expressing HttQ46-eGFP at age day 30 are shown in the control back-
ground (Ctrl) or together with the expression of an Atx2 RNAi KK line (Atx2 RNAi KK).
White dot circles label sLNvs without aggregates. Orange dash circles label sLNvs with aggre-
gates. Orange arrow heads indicate the lLNvs with aggregates while white arrow heads indicate
the lLNvs without aggregates. Example aggregates are pointed out by orange arrows.
(TIFF)
S6 Fig. Actograms for ATX2 overexpression with Htt. Double plotted actograms for individ-
ual flies that represent each genotype has behavior quantification in Fig 2A are shown under
5LD and 7DD cycles. Day number and Zeitgeber time is indicated on each actogram.
(TIFF)
S7 Fig. Actograms for overexpression of ATX2 domain deletion with Htt. Double plotted
actograms for individual flies from Fig 3A are shown under 5LD and 7DD cycles. Day number
and Zeitgeber time is indicated on each actogram.
(TIFF)
S8 Fig. Quantitative assessment of the strength of Atx2 related reagents. A. Rhythmic
power (P-S) is indicated for various genotypes including flies expressing three independent
overexpression line of ATX2 lacking PAM2 domain and one overexpression line of ATX2
lacking Lsm domain in PDF neurons (Atx2-dPAM#7/6/8 and Atx2-dLsm#9) with PdfGAL4 is
shown (Pdf>; n = 17–42; ⇤:p<0.05 ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard
error). B. Average FLAG intensity representing ATX2 level in sLNv (S) and lLNv (L) is indi-
cated for various genotypes including flies expressing three independent Atx2-dPAM (#7/6/8)
in the PDF neurons (n = 11–15; ⇤:p<0.05 ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard
error). C. Average PER intensity in sLNv is indicated for various genotypes including flies
expressing two RNAi lines Atx2 TRiP#2 and Atx2 KK, and three independent Atx2-dPAM
(#7/6/8) in the PDF neurons (n = 18–32; ⇤:p<0.05 ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent
standard error). D. Representative images for three independent Atx2-dPAM overexpression
lines (UAS-dPAM#7/6/8) expressed in PDF neurons and their negative control (W1118)
are shown. FLAG tagged ATX2 is stained by FLAG antibody and shown in red. PDF is stained
by PDF antibody and shown in green. Grey scale images of the green channel is show on the
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side of merged images.
(TIFF)
S9 Fig. tyfMutant does not affect mHtt sLNv cell loss nor aggregation. A. The number of
sLNv present per brain hemisphere is indicated for various genotypes at age day 10 under
wild-type control (+) or tyf mutant (tyf(e)) background with HttQ128 expressed in PDF neu-
rons is shown (n = 11–26; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard
error). B. The number of sLNv present per brain hemisphere is indicated for various genotypes
at age day 10 under wild-type control (+) or tyf mutant (tyf(e)) background is shown (n =
5–13; ⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard error). C. Percentage of
sLNvs at age day 7 containing HttQ72-eGFP aggregates in a wild-type control (+) or tyf
mutant (tyf(e)) background and expressing HttQ72 is quantified (n = 39–49; ⇤p<0.05,
⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard error). D. Representative images of LNvs
(sLNv and lLNv) for corresponding genotypes in C are shown. Orange dash circles label sLNvs
with aggregates while blue dot circles label sLNvs without aggregates in the grey scale of the
green channel. Example aggregates are pointed out by orange arrows. Flies from Figure are
shown under 5LD and 7DD cycles. Day number and Zeitgeber time is indicated on each acto-
gram.
(TIFF)
S10 Fig. Actograms for Atx2 related reagents and MJDQ78/TDP43. A. Double plotted acto-
grams for individual MJDQ78 flies from Fig 4A are shown under 5LD and 7DD cycles. Day
number and Zeitgeber time is indicated on each actogram. B. Double plotted actograms for
individual ATP43-A315T flies from Fig 4B are shown under 5LD and 7DD cycles. Day num-
ber and Zeitgeber time is indicated on each actogram.
(TIFF)
S11 Fig. Fmr1 TRiP RNAi lines reduce Fmr1 Transcript or GFP tagged FMR1 protein. A.
Relative RNA abundance of Fmr1 transcripts to Cam in each replicate for each genotype is
calculated and average of the relative RNA abundance of Fmr1 transcripts for three repliactes
for either control samples (elav TRiP Ctrl attP2) or Fmr1 RNAi expressing flies (elav Fmr1
TRiP#2) is shown (⇤p<0.05, ⇤⇤p<0.01, ⇤⇤⇤:p<0.005, error bars represent standard error). B.
Representative images of sLNvs and lLNvs for various genotypes including flies possessing
PdfGAL4 only (Fmr1-GFP Pdf-G4) or expressing Fmr1 RNAi in PDF neurons under a
Fmr1-GFP background (Fmr1-GFP Pdf>Fmr1 RNAi TRiP#1) are shown. PDF staining is
shown in red and FMR1-GFP staining is shown in green. Grey scale of the green channel of
each image is shown on the side. Red circles label sLNv or lLNv with both PDF and GFP sig-
nals. Dotted red circles label sLNv or lLNv without GFP signals.
(TIFF)
S12 Fig. Actograms for Fmr1 RNAi with Htt. A. Double plotted actograms for individual
HttQ0 or HttQ128 expressing flies from Fig 6A are shown under 5LD and 7DD cycles. Day
number and Zeitgeber time is indicated on each actogram. B. Double plotted actograms for
individual HttQ25 or HttQ103 expressing flies from Fig 6B are shown under 5LD and 7DD
cycles. Day number and Zeitgeber time is indicated on each actogram.
(TIFF)
S13 Fig. Actograms for Atx2 and Fmr1 RNAi with Htt. Double plotted actograms for indi-
vidual flies from Fig 7 in addition to Fig 6 are shown under 5LD and 7DD cycles. Day number
and Zeitgeber time is indicated on each actogram.
(TIFF)
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S14 Fig. Actograms for CrebA RNAi with Htt. A. Double plotted actograms for individual
HttQ0 or HttQ128 expressing flies from Fig 9A are shown under 5LD and 7DD cycles. Day
number and Zeitgeber time is indicated on each actogram. B. Double plotted actograms
for individual HttQ128 expressing flies from Fig 9B in addition to 9A are shown under
5LD and 7DD cycles. Day number and Zeitgeber time is indicated on each actogram. C.
Double plotted actograms for individual HttQ25 or HttQ103 expressing flies from Fig 9C are
shown under 5LD and 7DD cycles. Day number and Zeitgeber time is indicated on each
actogram.
(TIFF)
S15 Fig. Actograms for CREBA overexpression and Atx2 RNAi with Htt.Double plotted
actograms for individual HttQ0 or HttQ128 expressing flies from Fig 11 in addition to Fig 9
are shown under 5LD and 7DD cycles. Day number and Zeitgeber time is indicated on each
actogram.
(TIFF)
S1 Table. Pdf>HttQ0 sLNv number at D10.
(PDF)
S2 Table. Behavior summary of flies expressing Pdf>HttQ0 and HttQ128 with modifiers.
(PDF)
S3 Table. Behavior summary of flies expressing Pdf>HttQ25 and HttQ103 with modifiers.
(PDF)
S4 Table. Pdf>HttQ25/46/72 sLNv number at various ages.
(PDF)
S5 Table. Behavior data for GFP tagged Htt with different PolyQ expansions.
(PDF)
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